Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion type Assertion NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_head.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion description "[Dasatinib, a novel, oral, multitargeted kinase inhibitor of BCR-ABL and SRC family kinases, has previously induced responses in patients with imatinib-resistant or -intolerant Ph-positive ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion evidence source_evidence_literature NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion SIO_000772 17496201 NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion wasDerivedFrom befree-20150227 NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.
- NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_assertion wasGeneratedBy ECO_0000203 NP712132.RANIggHw9Mlx5T64OgPbDlhncmBdH7LLjN-ZybCl1Psbk130_provenance.